Literature DB >> 24592822

Perivascular stromal cells as a potential reservoir of human cytomegalovirus.

M A Soland1, L R Keyes, R Bayne, J Moon, C D Porada, S St Jeor, G Almeida-Porada.   

Abstract

Human cytomegalovirus (HCMV) infection is an important cause of morbidity and mortality among both solid organ and hematopoietic stem cell transplant recipients. Identification of cells throughout the body that can potentially serve as a viral reservoir is essential to dissect mechanisms of cell tropism and latency and to develop novel therapies. Here, we tested and compared the permissivity of liver-, brain-, lung (LNG)- and bone marrow (BM)-derived perivascular mesenchymal stromal cells (MSC) to HCMV infection and their ability to propagate and produce infectious virus. Perivascular MSC isolated from the different organs have in common the expression of CD146 and Stro-1. While all these cells were permissive to HCMV infection, the highest rate of HCMV infection was seen with LNG-MSC, as determined by viral copy number and production of viral particles by these cells. In addition, we showed that, although the supernatants from each of the HCMV-infected cultures contained infectious virus, the viral copy number and the quantity and timing of virus production varied among the various organ-specific MSC. Furthermore, using quantitative polymerase chain reaction, we were able to detect HCMV DNA in BM-MSC isolated from 7 out of 19 healthy, HCMV-seropositive adults, suggesting that BM-derived perivascular stromal cells may constitute an unrecognized natural HCMV reservoir. © Copyright 2014 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  Cytomegalovirus; HCMV; hematopoietic niche; pericytes; transplantation

Mesh:

Substances:

Year:  2014        PMID: 24592822      PMCID: PMC4046334          DOI: 10.1111/ajt.12642

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  58 in total

1.  Models of HCMV latency and reactivation.

Authors:  Daniel N Streblow; Jay A Nelson
Journal:  Trends Microbiol       Date:  2003-07       Impact factor: 17.079

2.  A perivascular origin for mesenchymal stem cells in multiple human organs.

Authors:  Mihaela Crisan; Solomon Yap; Louis Casteilla; Chien-Wen Chen; Mirko Corselli; Tea Soon Park; Gabriella Andriolo; Bin Sun; Bo Zheng; Li Zhang; Cyrille Norotte; Pang-Ning Teng; Jeremy Traas; Rebecca Schugar; Bridget M Deasy; Stephen Badylak; Hans-Jörg Buhring; Jean-Paul Giacobino; Lorenza Lazzari; Johnny Huard; Bruno Péault
Journal:  Cell Stem Cell       Date:  2008-09-11       Impact factor: 24.633

Review 3.  Participation of blood vessel cells in human adaptive immune responses.

Authors:  Jordan S Pober; George Tellides
Journal:  Trends Immunol       Date:  2011-10-24       Impact factor: 16.687

4.  Mesenchymal stem cells are susceptible to human herpesviruses, but viral DNA cannot be detected in the healthy seropositive individual.

Authors:  M Sundin; C Orvell; I Rasmusson; B Sundberg; O Ringdén; K Le Blanc
Journal:  Bone Marrow Transplant       Date:  2006-06       Impact factor: 5.483

5.  Human cytomegalovirus encodes a highly specific RANTES decoy receptor.

Authors:  Dai Wang; Wade Bresnahan; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-09       Impact factor: 11.205

6.  Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants.

Authors:  E M Borst; G Hahn; U H Koszinowski; M Messerle
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

7.  Selectable insertion and deletion mutagenesis of the human cytomegalovirus genome using the Escherichia coli guanosine phosphoribosyl transferase (gpt) gene.

Authors:  R F Greaves; J M Brown; J Vieira; E S Mocarski
Journal:  J Gen Virol       Date:  1995-09       Impact factor: 3.891

8.  Cytomegalovirus-induced immunopathology and its clinical consequences.

Authors:  Stefania Varani; Maria Paola Landini
Journal:  Herpesviridae       Date:  2011-04-07

9.  Modulation of human mesenchymal stem cell immunogenicity through forced expression of human cytomegalovirus us proteins.

Authors:  Melisa A Soland; Mariana G Bego; Evan Colletti; Christopher D Porada; Esmail D Zanjani; Stephen St Jeor; Graça Almeida-Porada
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

10.  Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors.

Authors:  M Mendelson; S Monard; P Sissons; J Sinclair
Journal:  J Gen Virol       Date:  1996-12       Impact factor: 3.891

View more
  11 in total

1.  The N Terminus of Human Cytomegalovirus Glycoprotein O Is Important for Binding to the Cellular Receptor PDGFRα.

Authors:  Cora Stegmann; Franziska Rothemund; Kerstin Laib Sampaio; Barbara Adler; Christian Sinzger
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

Review 2.  The silent war of CMV in aging and HIV infection.

Authors:  Rita B Effros
Journal:  Mech Ageing Dev       Date:  2015-09-25       Impact factor: 5.432

Review 3.  Mesenchymal Stromal Cells and Viral Infection.

Authors:  Maytawan Thanunchai; Suradej Hongeng; Arunee Thitithanyanont
Journal:  Stem Cells Int       Date:  2015-07-29       Impact factor: 5.443

Review 4.  Hemophilia A: an ideal disease to correct in utero.

Authors:  Christopher D Porada; Christopher Rodman; Glicerio Ignacio; Anthony Atala; Graça Almeida-Porada
Journal:  Front Pharmacol       Date:  2014-12-11       Impact factor: 5.810

Review 5.  Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Authors:  Lauren Stern; Barbara Withers; Selmir Avdic; David Gottlieb; Allison Abendroth; Emily Blyth; Barry Slobedman
Journal:  Front Microbiol       Date:  2019-05-28       Impact factor: 5.640

6.  Defining the Optimal FVIII Transgene for Placental Cell-Based Gene Therapy to Treat Hemophilia A.

Authors:  Nadia El-Akabawy; Martin Rodriguez; Ritu Ramamurthy; Andrew Rabah; Brady Trevisan; Alshaimaa Morsi; Sunil George; Jordan Shields; Diane Meares; Andrew Farland; Anthony Atala; Christopher B Doering; H Trent Spencer; Christopher D Porada; Graça Almeida-Porada
Journal:  Mol Ther Methods Clin Dev       Date:  2020-03-14       Impact factor: 6.698

7.  Development of a mouse salivary gland-derived mesenchymal cell line for immunological studies of murine cytomegalovirus.

Authors:  Timothy M White; Brent A Stanfield; Cassandra M Bonavita; Jared S Rudd; Rhonda D Cardin
Journal:  PLoS One       Date:  2022-08-17       Impact factor: 3.752

Review 8.  Review of the potential of mesenchymal stem cells for the treatment of infectious diseases.

Authors:  Amit Sharma; Anuja Chakraborty; Bithiah Grace Jaganathan
Journal:  World J Stem Cells       Date:  2021-06-26       Impact factor: 5.326

Review 9.  Impact of Viral Infections on Hematopoiesis: From Beneficial to Detrimental Effects on Bone Marrow Output.

Authors:  Maria Fernanda Pascutti; Martje N Erkelens; Martijn A Nolte
Journal:  Front Immunol       Date:  2016-09-16       Impact factor: 7.561

10.  Isolation, Characterization, Differentiation and Immunomodulatory Capacity of Mesenchymal Stromal/Stem Cells from Human Perirenal Adipose Tissue.

Authors:  Patrick C Baer; Benjamin Koch; Elena Hickmann; Ralf Schubert; Jindrich Cinatl; Ingeborg A Hauser; Helmut Geiger
Journal:  Cells       Date:  2019-10-29       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.